AusCann Group Holdings Ltd
Rank 67
About
AusCann is an Australian-based medical cannabis producer. They handle cultivation, production, manufacturing, and distribution of cannabinoid medicines. A partnership with Canopy Growth Corporation ensures patients have access to licensed cannabinoid formulations. Applications for their medicines include anti-inflammatory, anti-nausea, and anticonvulsant treatments.
$0.1095
USD
-2.86%
Market cap
$34,703,531
Total volume
$66,275
Shares outstanding
317,047,357
Rank 67
About
AusCann is an Australian-based medical cannabis producer. They handle cultivation, production, manufacturing, and distribution of cannabinoid medicines. A partnership with Canopy Growth Corporation ensures patients have access to licensed cannabinoid formulations. Applications for their medicines include anti-inflammatory, anti-nausea, and anticonvulsant treatments.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
AC8 |
$43,302
|
65.34% |
$0.1095
|
| ACNNF |
Total volume
$2,748
|
4.15% |
Stock price
$0.0990
|
Chart